| Target Price | CHF37.74 |
| Price | CHF16.20 |
| Potential |
132.96%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target R&S Group 2026 .
The average R&S Group target price is CHF37.74.
This is
132.96%
register free of charge
CHF43.58
168.98%
register free of charge
CHF28.28
74.57%
register free of charge
|
|
| A rating was issued by 11 analysts: 8 Analysts recommend R&S Group to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the R&S Group stock has an average upside potential 2026 of
132.96%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million CHF | 282.63 | 431.02 |
| 30.30% | 52.50% | |
| EBITDA Margin | 23.86% | 22.62% |
| 27.73% | 5.20% | |
| Net Margin | 14.58% | 14.98% |
| 171.95% | 2.74% |
6 Analysts have issued a sales forecast R&S Group 2025 . The average R&S Group sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an R&S Group EBITDA forecast 2025. The average R&S Group EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 R&S Group Analysts have issued a net profit forecast 2025. The average R&S Group net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | 1.31 | 1.74 |
| 227.50% | 32.82% | |
| P/E | 9.23 |
5 Analysts have issued a R&S Group forecast for earnings per share. The average R&S Group EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


